Granulocytic dysplasia: an indicator of clonal evolution in patients with chronic myeloid leukemia

Blood Research 2018³â 53±Ç 2È£ p.180 ~ p.181

(Rajpal Sweta) - Post Graduate Institute of Medical Education and Research Department of Hematology
(Nampoothiri Ram V.) - Post Graduate Institute of Medical Education and Research Department of Internal Medicine
(Sreedharanunni Sreejesh) - Post Graduate Institute of Medical Education and Research Department of Hematology
(Parihar Mayur) - Tata Medical Center Department of Cytogenetics and Laboratory Hematology
(Malhotra Pankaj) - Post Graduate Institute of Medical Education and Research Department of Internal Medicine
(Varma Neelam) - Post Graduate Institute of Medical Education and Research Department of Hematology

Abstract

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
A careful morphological evaluation of PBF continues to be important when accelerated phase of CML is suspected.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå